Last updated on April 2019

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations


Brief description of study

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Detailed Study Description

The purpose of this study is to evaluate the overall response rate (ORR) of INCB054828 as a monotherapy in the treatment of metastatic or surgically unresectable urothelial carcinoma harboring FGF/FGFR alterations.

Clinical Study Identifier: TX152594

Contact Investigators or Research Sites near you

Start Over

Saitama Cancer Center

Kitaadachi-gun, Japan
  Connect »

Zorgsaam Ziekenhuis

Terneuzen, Netherlands
  Connect »

UZ Antwerpen

Edegem, Belgium
  Connect »

AZ Delta

Roeselare, Belgium
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

VU Medisch Centrum

Amsterdam, Netherlands
  Connect »

Queen Elizabeth Hospital

Birmingham, United Kingdom
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Charing Cross Hospital

London, United Kingdom
  Connect »

St. Luke's Hospital

Bethlehem, PA United States
  Connect »

Lahey Clinic Inc.

Burlington, MA United States
  Connect »

Oncology Hematology Care, Inc.

Cincinnati, OH United States
  Connect »

Texas Oncology

Houston, TX United States
  Connect »

Mount Sinai Medical Center

Miami Beach, FL United States
  Connect »

Carolina Urologic Research Center

Myrtle Beach, SC United States
  Connect »

GU Research Network

Omaha, NE United States
  Connect »

VA Pittsburgh Healthcare System

Pittsburgh, PA United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Huntsman Cancer Institute

Salt Lake City, UT United States
  Connect »

Sharp Memorial Hospital

San Diego, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.